Zura Bio Ownership | Who Owns Zura Bio?
Zura Bio Ownership Summary
Zura Bio is owned by 17.45% institutional investors, 24.49% insiders, and 58.06% retail investors. Suvretta capital management is the largest institutional shareholder, holding 5.80% of ZURA shares.
ZURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Zura Bio | 17.45% | 24.49% | 58.06% |
| Sector | Healthcare Stocks | 232.63% | 10.66% | -143.29% |
| Industry | Biotech Stocks | 382.12% | 10.42% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 5.47M | 5.80% | $23.70M |
| Vr adviser | 4.63M | 4.91% | $20.05M |
| Jpmorgan chase | 4.47M | 4.73% | $23.44M |
| Great point partners | 3.82M | 4.05% | $16.52M |
| Adage capital partners gp | 3.05M | 3.23% | $13.19M |
| Pfizer | 2.97M | 3.14% | $15.56M |
| Braidwell lp | 2.47M | 2.62% | $10.71M |
| Ikarian capital | 2.13M | 2.26% | $9.23M |
| Armistice capital | 1.56M | 1.65% | $6.75M |
| Morgan stanley | 1.51M | 1.60% | $7.91M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Great point partners | 3.82M | 6.81% | $16.52M |
| Pfizer | 2.97M | 6.58% | $15.56M |
| Vr adviser | 4.63M | 1.13% | $20.05M |
| Ikarian capital | 2.13M | 0.93% | $9.23M |
| Suvretta capital management | 5.47M | 0.61% | $23.70M |
| Affinity asset advisors | 1.27M | 0.48% | $5.52M |
| Braidwell lp | 2.47M | 0.32% | $10.71M |
| Adar1 capital management | 652.15K | 0.27% | $2.82M |
| Armistice capital | 1.56M | 0.10% | $6.75M |
| Boothbay fund management | 824.08K | 0.05% | $3.57M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 3.05M | 0.02% | 3.05M |
| Ikarian capital | 2.13M | 0.93% | 2.13M |
| Morgan stanley | 1.51M | 0.00% | 1.30M |
| Affinity asset advisors | 1.27M | 0.48% | 1.05M |
| Boothbay fund management | 824.08K | 0.05% | 824.08K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.22M |
| Allostery investments lp | - | - | -2.33M |
| Point72 asset management | 726.33K | 0.01% | -1.62M |
| Silverarc capital management | - | - | -720.45K |
| Woodline partners lp | - | - | -520.28K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adage capital partners gp | 3.05M | 0.02% | 3.05M | $13.19M |
| Ikarian capital | 2.13M | 0.93% | 2.13M | $9.23M |
| Boothbay fund management | 824.08K | 0.05% | 824.08K | $3.57M |
| Ameriprise financial | 500.00K | 0.00% | 500.00K | $2.17B |
| Bridgeway capital management | 118.00K | 0.01% | 118.00K | $510.92K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -14.00 |
| Sterling capital management | -53.00 |
| True wealth design | -78.00 |
| Clearstead advisors | -239.00 |
| Wells fargo & company/mn | -385.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 35 | -50.70% | 16,505,575 | -59.89% | 17 | 0.92% | 22 | -35.29% | 8 | -65.22% |
| Sep 30, 2025 | 68 | 15.25% | 39,551,293 | 14.18% | 41 | 1.49% | 33 | - | 21 | 31.25% |
| Jun 30, 2025 | 62 | -17.33% | 35,347,572 | -22.51% | 54 | 2.25% | 36 | 20.00% | 16 | -23.81% |
| Mar 31, 2025 | 75 | -18.48% | 45,725,362 | 6.61% | 49 | 2.04% | 31 | -44.64% | 21 | 90.91% |
| Dec 31, 2024 | 92 | 9.52% | 42,888,901 | 15.28% | 49 | 2.71% | 56 | -1.75% | 11 | 37.50% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 26, 2026 | AI Biotechnology LLC | - | Buy | $12.50M |
| Oct 30, 2023 | Sidhu Someit | - | Buy | $28.52M |
| Nov 25, 2024 | Thiara Parvinder | - | Sell | $2.73M |
| Sep 11, 2024 | Thiara Parvinder | - | Sell | $10.26M |
| Sep 04, 2024 | Sidhu Someit | - | Sell | $200.19K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
ZURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools